HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplements Mixed With Direct Selling A Recipe Ripe For Cooking US FTC Regulation Violations

Executive Summary

Doesn’t take long to find health and wellness product marketers on list of direct sellers or find firms offering those products in the FTC's history of enforcement actions in the sector. 

You may also be interested in...



Health Care Professionals Settle With FTC Over COVID-19 Claims For Direct Seller’s Supplements

Three distributors made claims doTerra's essential oils and supplements could treat or prevent COVID-19 in early 2022webinars. They also underscored medical expertise in recommending products.

Direct Selling Self-Regulation Group Has Questions For FTC On Another Supplement Marketer

BBB National Programs’ Direct Selling Self-Regulatory Council made multiple attempts beginning in October to ask ViaSalus for evidence substantiating weight loss claims for supplements independent sales associates sell and income claims the firm makes.

Herbalife Pays $123M To Resolve Criminal, Civil Charges From US Investigation Of China Business

Direct seller pays fines in settlements with SEC and DoJ on bribery and other charges but two former executives for its operations in China still face criminal charges alleging violations of the Foreign Corrupt Practices Act. They have not been arrested and have remained at large since being charged in November 2019.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel